-
Type:
Change Request
-
Resolution: Persuasive
-
Priority:
Medium
-
FHIR Core (FHIR)
-
R5
-
Biomedical Research & Regulation
-
DomainResource
-
-
Peter Bomberg/Catherine Hosage Norman: 19-0-0
-
Enhancement
-
Compatible, substantive
-
R5
Background: PQ/CMC has a requirement to capture drug product impurities. These impurities are substances.
Request adding a new element called impurity to MedicialProductDefinition
Element name: impurity (0..*) References SubstanceDefinition Resource
Definition: Any component of the drug product which is not the chemical entity defined as the drug substance or an excipient in the drug product. This includes process-related impurities and contaminants, product-related impurities including degradation products. [Source: Adapted from ICH Q6A and ICH Q6B ]